About
TissueTech develops and markets human amniotic membrane-based allograft products used in regenerative medicine for surgical, ocular, and chronic wound care applications.
Explore TissueTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.